Z29.11
Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV)
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code Z29.11 refers to medical encounters where patients receive prophylactic immunotherapy to prevent respiratory syncytial virus (RSV) infection. RSV is a common respiratory virus that usually causes mild symptoms but can lead to serious illness, especially in infants, young children, and older adults. Preventive immunotherapy plays a crucial role in reducing the risk of severe RSV disease, particularly for high-risk populations. This article provides an overview of the purpose of prophylactic immunotherapy for RSV, its typical use cases, and what patients can expect during such medical encounters.
Causes & Symptoms
Clinical Causes: Premature birth, especially before 35 weeks of gestation Infants under 6 months of age at the start of RSV season Children with congenital heart disease or chronic lung disease Immunocompromised patients, including those undergoing chemotherapy or with immune deficiencies Older adults with significant underlying health conditions that predispose them to respiratory infections
Key Symptoms: Runny nose Reduced appetite Coughing Sneezing Fever Wheezing or difficulty breathing in more severe cases Decreased activity levels in infants
Diagnostic & Treatment
Diagnosis Path: The focus of this encounter is not on diagnosing RSV but on administering preventive treatment. However, if RSV infection is suspected, diagnostic methods such as nasopharyngeal swabs, PCR testing, or rapid antigen testing may be used. Prior to prophylactic therapy, healthcare providers consider the patient's risk factors and medical history to determine the appropriateness of treatment.
Treatment Protocols: Monthly injections of palivizumab throughout the RSV season Monitoring for allergic reactions or adverse effects post-injection Coordination with the healthcare team to assess ongoing risk and necessity of continued therapy
Clinical Advice & FAQs
Billing Guidance
Is Z29.11 a billable ICD-10 code?
Yes, Z29.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z29.11?
Clinical documentation must specify the nature of Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference